-
1
-
-
85120125857
-
-
British Journal of Sports Medicine policy on ethics, available at: http://bjsm.bmj.com/ifora/ethics.dtl (accessed June 4, 2007).
-
-
-
-
2
-
-
85120094064
-
-
National Statement on Ethical Conduct in Human Research, available at: http://www.nhmrc.gov.au/publications/synopses/_files/e72.pdf (accessed June 4, 2007).
-
-
-
-
3
-
-
19744380776
-
Adenomatous polyp prevention on Vioxx (APPROVe) trial investigators cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
-
R.S. Bresalier R.S. Sandler H. Quan J.A. Bolognese B. Oxenius K. Horgan Adenomatous polyp prevention on Vioxx (APPROVe) trial investigators cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 11 2005 1092 1102 Mar 17, Epub 2005 Feb 15. Erratum in: N Engl J Med 2006 Jul 13;355(2):221
-
(2005)
N Engl J Med
, vol.352
, Issue.11
, pp. 1092-1102
-
-
Bresalier, R.S.1
Sandler, R.S.2
Quan, H.3
Bolognese, J.A.4
Oxenius, B.5
Horgan, K.6
-
4
-
-
0242556418
-
Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data
-
D. Layton E. Heeley K. Hughes S.A. Shakir Comparison of the incidence rates of thromboembolic events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data Rheumatology (Oxford) 42 11 2003 1342 1353
-
(2003)
Rheumatology (Oxford)
, vol.42
, Issue.11
, pp. 1342-1353
-
-
Layton, D.1
Heeley, E.2
Hughes, K.3
Shakir, S.A.4
-
5
-
-
19544394710
-
Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme
-
M. Harrison-Woolrych P. Herbison R. McLean J. Ashton J. Slattery Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme Drug Saf 28 5 2005 435 442
-
(2005)
Drug Saf
, vol.28
, Issue.5
, pp. 435-442
-
-
Harrison-Woolrych, M.1
Herbison, P.2
McLean, R.3
Ashton, J.4
Slattery, J.5
-
6
-
-
33644847670
-
Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study
-
W.F. Huang F.Y. Hsiao Y.W. Tsai Y.W. Wen Y.T. Shih Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study Drug Saf 29 3 2006 261 272
-
(2006)
Drug Saf
, vol.29
, Issue.3
, pp. 261-272
-
-
Huang, W.F.1
Hsiao, F.Y.2
Tsai, Y.W.3
Wen, Y.W.4
Shih, Y.T.5
-
7
-
-
27944436601
-
The use of diagnostic imaging in sports medicine
-
J.W. Orchard J.W. Read I.J. Anderson The use of diagnostic imaging in sports medicine Med J Aust 183 9 2005 482 486 Nov 7
-
(2005)
Med J Aust
, vol.183
, Issue.9
, pp. 482-486
-
-
Orchard, J.W.1
Read, J.W.2
Anderson, I.J.3
-
8
-
-
84883836027
-
The teratogenic action of drugs
-
W. McBride The teratogenic action of drugs Med J Aust 26 41 1963 689 692
-
(1963)
Med J Aust
, vol.26
, Issue.41
, pp. 689-692
-
-
McBride, W.1
|